- Like
- SHARE
- Digg
- Del
- Tumblr
- VKontakte
- Flattr
- Buffer
- Love This
- Save
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- JOIN
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
Synergy Pharmaceuticals is a multinational organisation at the forefront of scientific research and new product development focusing on viral diseases. After years of research and testing Synergy have been successful in developing a product that has cured people infected with herpes. This medical breakthrough is set to revolutionise the medical associations approach to viral diseases.
What Synergy has achieved is perhaps the greatest medical breakthrough of the decade. This is the first time that evidence has proven that subjects who were infected by the Herpes Simplex Virus have undergone a treatment and then shown with further medical evidence that they have been cured from the disease. This has never been achieved before and it brings us one step closer to ending herpes worldwide.
![](https://www.cure4herpes.com/wp-content/uploads/2018/08/Life-science-researcher.jpg)
This all natural, no prescription required treatment works by boosting the immune system and targeting the source of the virus. Results have repeatedly proven that this is the world’s first product that has completely cured people with herpes (HSV-1 & HSV-2). Not suppressing the herpes virus but actually completely eliminating it, leaving them with absolutely no medical trace of the virus. The key ingredient to this combination is our Amino Acid Formula which may also hold the answer to many other serious health conditions. For more information, please visit the website at www.cure4herpes.com
Synergy’s clinical research trials assessed subjects who were infected with the genital herpes virus (HSV-1 & HSV-2). A longitudinal approach was adopted, where participants infection rates were measured at various points for the duration of the treatment. Many of the participants had been infected for many years, as such an IgG herpes antibody serology blood test analysis was applied rather than an IgM analysis. The IgG index levels were monitored with specific markers throughout the study to assess the effectiveness of the treatment and the progress made. Initially, each ingredient was tested independently with participants, however, this proved ineffective. It was only when the combination of ingredients was applied that the levels of herpes cellular reproduction and activity declined.
The length of the treatment found to be most effective for a successful outcome was 4-6 months. The trials conducted proved that in 80% of subjects verified as being positive to the herpes simplex virus at the commencement, were after 6 months shown to have negative blood test results to herpes. This therefore reflected that they were no longer infected, had no herpes related symptoms or outbreaks and were no longer carriers of the virus. Follow up blood tests found there was no re-occurrence of the virus, validating that once the viral cells are destroyed, it does not re-emerge. The remaining 20% of participants who were still above the IgG markers reported a significant decline in herpes antibody activity. Correspondingly, their previous regular pattern and severity of outbreaks was greatly reduced. Additional benefits to their immune system function and overall health were also reported.
Since the early research trials, we have gone on to continue reproducing the same amazing results for sufferers of genital and oral herpes alike. There are no reported side effects and in fact people undertaking the treatment have only reported improvements to their mood, energy levels and physical wellbeing. The proprietary blend amino acid is a very powerful antigen. It works to repair cells throughout the body including the skin and as such it can bring a notably healthier and younger looking appearance.
Final Thoughts
It is important to note that while Synergy’s clinical trial results are promising, once the subject has been cured and no trace of the herpes virus is present they do not have any immunity to the virus. This is because the antibodies the body develops are only in response to one strain of the virus. As such they do not possess immunity to all strains and if exposed to the herpes virus again through external means they may be reinfected.
About Shannon Clark
Shannon holds a degree in Exercise Science and is a certified personal trainer and fitness writer with over 10 years of industry experience.